Publications

1. Schüz J, Soerjomataram I, Foerster M, Langselius O, Rohrmann S, Vineis P, et al. (2025). Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities. J Natl Cancer Inst. 117(12):2432–40.
   https://doi.org/10.1093/jnci/djaf182 PMID:40668754
2. Schüz J, Kovalevskiy E, Olsson A, Moissonnier M, Ostroumova E, Ferro G, et al. (2024). Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study). J Natl Cancer Inst. 116(6):866–75.
   https://doi.org/10.1093/jnci/djad262 PMID:38247448
3. Rodet N, Zahed H, Colombet M, Bray F, McCormack V (2025). Understanding age and sex differentials in cancer incidence and mortality: an international population-based study. Int J Cancer. ijc.70244.
   https://doi.org/10.1002/ijc.70244 PMID:41208540
4. Olsson A, Bouaoun L, Schüz J, Vermeulen R, Behrens T, Ge C, et al. (2024). Lung cancer risks associated with occupational exposure to pairs of five lung carcinogens: results from a pooled analysis of case-control studies (SYNERGY). Environ Health Perspect. 132(1):17005.
   https://doi.org/10.1289/EHP13380 PMID:38236172
5. Olsson A, Schüz J, Bukhtiyarov I, Moissonnier M, Ostroumova E, Ferro G, et al. (2025). Cause-specific mortality among workers in asbestos mining and enrichment factories (Asbest Chrysotile Cohort Study) compared with the general population of Sverdlovsk Oblast, Russian Federation. J Occup Med Toxicol. 20(1):37.
   https://doi.org/10.1186/s12995-025-00484-3 PMID:41199374
6. Narh CT, Afetor M, Baiden FE, Agbeko A, Commeh ME, Aziato L, et al.; ABC-DO Ghana team (2025). Barriers to breast cancer care for women presenting at district and regional-level hospitals in Ghana: findings from the African Breast Cancer-Disparities in Outcomes Ghana study. JCO Glob Oncol. 11(11):e2500275.
   https://doi.org/10.1200/GO-25-00275 PMID:41160780
7. Mo T, Joffe M, Cubasch H, Galukande M, Parham G, Pinder L, et al. (2025). Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 13(10):e1681–90.
   https://doi.org/10.1016/S2214-109X(25)00273-6 PMID:40975077
8. Mo T, Zins M, Goldberg M, Ribet C, Kab S, Schreiver I, et al. (2025). Tattoos and risk of cutaneous melanoma and non-melanoma skin cancer in France. J Natl Cancer Inst. Nov 19:djaf332.
   https://doi.org/10.1093/jnci/djaf332 PMID:41259064
9. Maroui MA, Odongo GA, Mundo L, Manara F, Mure F, Fusil F, et al. (2024). Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection. Proc Natl Acad Sci U S A. 121(16):e2314426121.
   https://doi.org/10.1073/pnas.2314426121 PMID:38574017
10. Laplanche A, Guida F, Moissonnier M, Launay L, Beranger R, Lagroye I, et al. (2025). Associations between individual and geospatial characteristics and power of 4G signals received by mobile phones. Environ Res. 286(Pt 3):123030.
    https://doi.org/10.1016/j.envres.2025.123030 PMID:41061881
11. Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. (2025). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 31(4):1154–62.
    https://doi.org/10.1038/s41591-025-03502-3 PMID:39994475
12. Ghantous A, Nusslé SG, Nassar FJ, Spitz N, Novoloaca A, Krali O, et al. (2024). Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth. Mol Cancer. 23(1):238.
    https://doi.org/10.1186/s12943-024-02118-4 PMID:39443995
13. Espina C, Ritchie D, Feliu A, Canelo-Aybar C, D’Souza E, Mitrou PN, et al. (2026). Developing evidence-based cancer prevention recommendations: methodology of the World Code Against Cancer Framework to create region-specific codes. Int J Cancer. 158(1):9–18.
    https://doi.org/10.1002/ijc.70068 PMID:40741905
14. Drozdovitch V, Lipikhina A, Apsalikov K, Brait Y, Tokanov A, Yessilkanov G, et al. (2025). Thyroid doses estimated for a cohort of people exposed to fallout from atmospheric nuclear weapons testing at the Semipalatinsk nuclear test site, Kazakhstan. Radiat Environ Biophys.
    https://doi.org/10.1007/s00411-025-01155-x PMID:41247536
15. Drozdovitch V, Lipikhina A, Apsalikov K, Brait Y, Tokanov A, Yessilkanov G, et al. (2025). Assessment of radiation contamination of villages in northeastern Kazakhstan not covered by exposure rate measurements after atmospheric nuclear weapons tests conducted at the Semipalatinsk nuclear test site. J Environ Radioact. 288:107731.
    https://doi.org/10.1016/j.jenvrad.2025.107731 PMID:40499259
16. Chavanel B, Virard F, Cahais V, Renard C, Sirand C, Smits KM, et al. (2024). Genome-scale mutational signature analysis in archived fixed tissues. Mutat Res Rev Mutat Res. 794:108512.
    https://doi.org/10.1016/j.mrrev.2024.108512 PMID:39216514
17. Boucheron P, Zietsman A, Anele A, Offiah AU, Galukande M, Parham G, et al. (2025). Measuring the WHO Global Breast Cancer Initiative Pillars’ key performance indicators in Sub-Saharan Africa: experience in the African Breast Cancer-Disparities in Outcomes hospital-based cohort study. EClinicalMedicine. 81:103104.
    https://doi.org/10.1016/j.eclinm.2025.103104 PMID:40034567
18. Bouaoun L, Byrnes G, Lagorio S, Feychting M, Abou-Bakre A, Béranger R, et al. (2024). Effects of recall and selection biases on modeling cancer risk from mobile phone use: results from a case-control simulation study. Epidemiology. 35(4):437–46.
    https://doi.org/10.1097/EDE.0000000000001749 PMID:38771708
    Winner of the prestigious Rothman Prize in 2025. https://journals.lww.com/epidem/fulltext/2025/07000/liacine_bouaoun,_winner_of_the_2025_rothman_prize.1.aspx